Child pneumonia - focus on the Western Pacific Region

T K P Nguyen1, T H Tran2, C L Roberts3

  • 1Discipline of Paediatrics and Adolescent Medicine, The Children's Hospital at Westmead, The University of Sydney, Australia; Da Nang Hospital for Women and Children, Da Nang, Viet Nam.

Insights

Pneumonia remains a major global threat to young children, causing significant deaths, especially in the Western Pacific Region. Evolving causes and increased vaccination necessitate updated management strategies for child pneumonia.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Pneumonia is the primary cause of mortality in children under five globally.
  • The WHO Western Pacific Region faces a substantial burden of childhood pneumonia, with high mortality rates in specific countries.

Purpose of the Study:

  • To provide an overview of the global pneumonia disease burden.
  • To examine the etiology and management of pneumonia, focusing on the WHO Western Pacific Region.
  • To highlight the impact of conjugate vaccines and socio-economic development on pneumonia trends.

Main Methods:

  • Review of global pneumonia disease burden.
  • Analysis of etiological factors and management practices.
  • Focus on data from the WHO Western Pacific Region.

Main Results:

  • In 2011, the Western Pacific Region recorded 61,900 pneumonia deaths in children under five.
  • Over 75% of these deaths were concentrated in Cambodia, China, Laos, Papua New Guinea, the Philippines, and Viet Nam.
  • The etiological landscape is shifting from Streptococcus pneumoniae and Haemophilus influenzae towards viruses and atypical bacteria, influenced by vaccine introduction and development.

Conclusions:

  • Traditional pneumonia case management may need revision due to increased conjugate vaccine uptake.
  • Risk reduction, enhanced vaccination, improved hypoxemia management, and antibiotic stewardship are crucial.
  • Addressing the changing epidemiology of childhood pneumonia is vital for reducing mortality in the Western Pacific Region.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
612